Singapore markets close in 2 hours 12 minutes

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
41.93-0.60 (-1.41%)
As of 02:33PM CST. Market open.
Currency in CNY

Valuation measures4

Market cap (intra-day) 271.30B
Enterprise value 249.60B
Trailing P/E 60.76
Forward P/E 59.52
PEG ratio (5-yr expected) N/A
Price/sales (ttm)11.54
Price/book (mrq)6.48
Enterprise value/revenue 10.70
Enterprise value/EBITDA 51.59

Trading information

Stock price history

Beta (5Y monthly) 0.20
52-week change 3-9.09%
S&P500 52-week change 324.71%
52-week high 350.50
52-week low 335.51
50-day moving average 344.19
200-day moving average 344.16

Share statistics

Avg vol (3-month) 324.94M
Avg vol (10-day) 325.25M
Shares outstanding 56.38B
Implied shares outstanding 66.69B
Float 83.5B
% held by insiders 148.59%
% held by institutions 116.73%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.16
Forward annual dividend yield 40.38%
Trailing annual dividend rate 30.20
Trailing annual dividend yield 30.47%
5-year average dividend yield 40.32
Payout ratio 422.86%
Dividend date 3N/A
Ex-dividend date 408 Jun 2023
Last split factor 21.2:1
Last split date 310 Jun 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 19.00%
Operating margin (ttm)24.64%

Management effectiveness

Return on assets (ttm)6.22%
Return on equity (ttm)10.77%

Income statement

Revenue (ttm)23.32B
Revenue per share (ttm)3.69
Quarterly revenue growth (yoy)9.20%
Gross profit (ttm)N/A
EBITDA 5.09B
Net income avi to common (ttm)4.43B
Diluted EPS (ttm)0.70
Quarterly earnings growth (yoy)10.50%

Balance sheet

Total cash (mrq)21.77B
Total cash per share (mrq)3.34
Total debt (mrq)78.4M
Total debt/equity (mrq)0.19%
Current ratio (mrq)9.12
Book value per share (mrq)6.42

Cash flow statement

Operating cash flow (ttm)8.68B
Levered free cash flow (ttm)5.96B